Page last updated: 2024-11-02

pentoxifylline and Affective Disorders

pentoxifylline has been researched along with Affective Disorders in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Pentoxifylline (PTX) is a phosphodiesterase inhibitor with potent anti-inflammatory and antioxidant effects, with additional pleiotropic effects that lead to improved CBF and increases in brain derived neurotrophic factor (BDNF) levels."6.72Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. ( Gill, H; Goldstein, BI; Ho, R; Lee, Y; Lipsitz, O; Lui, LMW; Majeed, A; Mansur, RB; McIntyre, RS; Nasri, F; Phan, L; Rashidian, H; Rodrigues, N; Rosenblat, JD; Siegel, AN; Subramaniapillai, M; Toma, S; Wilkialis, L, 2021)
"Pentoxifylline (PTX) is a phosphodiesterase inhibitor with potent anti-inflammatory and antioxidant effects, with additional pleiotropic effects that lead to improved CBF and increases in brain derived neurotrophic factor (BDNF) levels."2.72Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. ( Gill, H; Goldstein, BI; Ho, R; Lee, Y; Lipsitz, O; Lui, LMW; Majeed, A; Mansur, RB; McIntyre, RS; Nasri, F; Phan, L; Rashidian, H; Rodrigues, N; Rosenblat, JD; Siegel, AN; Subramaniapillai, M; Toma, S; Wilkialis, L, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Siegel, AN1
Rodrigues, N1
Nasri, F1
Wilkialis, L1
Lipsitz, O1
Lee, Y1
Gill, H1
Subramaniapillai, M1
Phan, L1
Majeed, A1
Lui, LMW1
Rashidian, H1
Ho, R1
Toma, S1
Goldstein, BI1
Mansur, RB1
McIntyre, RS1
Rosenblat, JD1

Reviews

1 review available for pentoxifylline and Affective Disorders

ArticleYear
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
    Progress in neuro-psychopharmacology & biological psychiatry, 2021, 01-10, Volume: 104

    Topics: Animals; Antidepressive Agents; Antimanic Agents; Drug Delivery Systems; Free Radical Scavengers; Hu

2021